Exploring immunogenic CD8 + T-cell epitopes for peptide-based vaccine development against evolving SARS-CoV-2...

Area of Science:

• Immunology
• Virology
• Computational Biology

Background:

• The COVID-19 pandemic, caused by SARS-CoV-2, has led to significant global mortality.
• Current vaccines target the Spike protein but face challenges due to viral mutations and immune evasion.
• Evolving SARS-CoV-2 variants necessitate novel vaccine strategies for sustained protection.

Purpose of the Study:

• To identify immunogenic CD8+ T-cell epitopes (CTLs) from conserved regions of SARS-CoV-2 proteins.
• To evaluate the potential of these epitopes for developing broadly protective peptide-based vaccines.
• To computationally validate the stability and interactions of identified epitopes with HLA molecules.

Main Methods:

• Immunoinformatics approach for epitope prediction from SARS-CoV-2 Spike, Membrane, Nucleocapsid, and Envelope proteins.
• In silico evaluation of epitope conservation, toxicity, human homology, and population coverage.
• Molecular docking and molecular dynamics simulations to assess epitope-HLA interactions.

Main Results:

• Identified 21 potentially immunogenic CTL epitopes, with 15 from the Spike protein.
• Twenty identified epitopes matched experimentally verified ones, including a novel Spike protein epitope (NTQEVFAQV).
• Epitopes demonstrated high conservation across SARS-CoV-2 variants, non-toxicity, no human homology, and broad population coverage.

Conclusions:

• The identified conserved epitopes offer a promising foundation for developing effective peptide vaccines against SARS-CoV-2.
• The immunoinformatics framework provides a robust method for designing vaccines against mutating viruses.
• These findings could significantly advance the development of next-generation SARS-CoV-2 peptide vaccines.